Suppr超能文献

移动医疗(mHealth)技术在高血压和高脂血症管理中的应用:缓慢起步但潜力巨大。

Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of Potential.

机构信息

Houston Methodist Hospital, Houston, TX, USA.

The Aga Khan University Medical College, Karachi, Pakistan.

出版信息

Curr Atheroscler Rep. 2017 Mar;19(3):12. doi: 10.1007/s11883-017-0649-y.

Abstract

PURPOSE OF REVIEW

Hypertension and hyperlipidemia represent two major risk factors for atherosclerotic cardiovascular disease. Mobile health or mHealth is defined as the use of mobile phone and wireless technologies to support the achievement of health objectives. Management of hypertension, and to some extent hyperlipidemia, has often employed mHealth interventions given lower cost and greater patient engagement compared to traditional methods. These interventions include the use of text messaging, wireless devices, and mobile phone applications. This review considers recent studies evaluating the effectiveness of mHealth interventions in the management of hypertension and hyperlipidemia.

RECENT FINDINGS

Numerous studies have evaluated the role of mHealth interventions in the management of hypertension, while very few have evaluated their role in hyperlipidemia. Text messaging has been used most frequently. However, the trend is shifting towards the use of mobile phone applications and wireless devices. Interventions in developing countries have been modified for greater applicability to local settings. mHealth interventions were found to be frequently effective. However, studies comparing the relative efficacy of various mHealth strategies are scarce. Long-term cardiovascular outcomes data and analyses relating to cost effectiveness are also lacking. mHealth interventions may be effective in improving hypertension management. More studies are needed to evaluate the role of mHealth strategies in hyperlipidemia management, particularly in identifying high-risk individuals and improving medication adherence. Studies assessing the long-term impact of these interventions, comparing different interventions and analyzing their relative cost effectiveness, are also needed. Following recently published guidelines on reporting results of mHealth interventions will provide a more meaningful context for interpreting these promising early studies.

摘要

目的综述

高血压和高血脂是动脉粥样硬化性心血管疾病的两个主要危险因素。移动医疗或 mHealth 定义为使用移动电话和无线技术来支持实现健康目标。与传统方法相比,移动医疗干预措施在高血压的管理中,在一定程度上也适用于高血脂的管理,因为其成本更低,患者参与度更高。这些干预措施包括使用短信、无线设备和移动应用程序。本综述考虑了最近评估 mHealth 干预措施在高血压和高血脂管理中的有效性的研究。

最近的发现

许多研究评估了 mHealth 干预措施在高血压管理中的作用,而很少有研究评估它们在高血脂管理中的作用。短信的使用最为频繁。然而,趋势正在转向使用移动应用程序和无线设备。发展中国家的干预措施已经进行了修改,以更适应当地的情况。mHealth 干预措施经常被证明是有效的。然而,比较各种 mHealth 策略相对有效性的研究很少。也缺乏关于长期心血管结局数据和与成本效益相关的分析。mHealth 干预措施可能有助于改善高血压管理。需要更多的研究来评估 mHealth 策略在高血脂管理中的作用,特别是在识别高危人群和提高药物依从性方面。还需要评估这些干预措施的长期影响,比较不同的干预措施并分析其相对成本效益的研究。遵循最近发布的关于报告 mHealth 干预措施结果的指南,将为解释这些有前途的早期研究提供更有意义的背景。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验